BSE filing, BSE: 544310. Summary written from the filing by ALFA Finder's alert engine.
Yash Highvoltage Ltd: key numbers
- Share price
- ₹1,242.00
- Market cap
- ₹3,713 Cr
- Revenue (annual)
- ₹235.2 Cr
- Net profit (annual)
- ₹37.32 Cr
- P/E (TTM)
- 99.5×Sector 52.0×
- Promoter holding
- 53.79%
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Yash Highvoltage Ltd
All →Yash Highvoltage Earnings Call Transcript: Key Takeaways
Yash Highvoltage delivers explosive 95% YoY revenue growth, driven by domestic infrastructure demand and pricing power.
- Call
- Guides 414% growth
Yash Highvoltage Employee Stock Options
Yash Highvoltage Limited has allotted 9,200 equity shares following the exercise of vested employee stock options under its ESOP Scheme 2025.
Yash Highvoltage Results Update
Yash Highvoltage's H1 FY27 revenue grew 95% YoY to ₹194.5 crore, with EBITDA rising to ₹54.7 crore and PAT to ₹36.2 crore.
Yash Highvoltage Investor Presentation: Key Takeaways
Yash Highvoltage reported strong H1FY27 performance with revenue growth of 95% YoY. Management highlights international expansion, specifically in the US, and upcoming commissioning of a new greenfield facility for backward integration.
- Call
- Guides 300% growth
Yash Highvoltage H1 FY27 Results: Net Profit ₹36.4 Cr, Up 165.7% QoQ
Yash Highvoltage Ltd reported revenue from operations of ₹194.5 Cr and net profit of ₹36.4 Cr for H1 FY27.
- Key figure
- Net profit ₹36.4 Cr
Yash Highvoltage Partnership
Yash Highvoltage's subsidiary, YASH HV USA INC., appointed EHV Solutions LLC as a sales representative for 3 years to expand US market presence.
- Execution
- 36 months
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.